Fosdevirine

Fosdevirine is an experimental antiviral agent of the non-nucleoside reverse transcriptase inhibitor class that was studied for potential use in the treatment of HIV-AIDS. It was discovered by Idenix Pharmaceuticals and was being developed by GlaxoSmithKline and ViiV Healthcare, but it has now been discontinued due to unexpected side effects.
Wikipedia contributors, "Fosdevirine", Wikipedia, revision 1330818530, retrieved 20 November 2026, source, CC BY-SA 4.0.